📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroids (2015)

First Author: Ibrahim F

Attributed to: CIMA: The Centre for Integrated Research into Musculoskeletal Ageing funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/keu442

PubMed Identifier: 25433040

Publication URI: http://europepmc.org/abstract/MED/25433040

Type: Journal Article/Review

Parent Publication: Rheumatology

Issue: 6

ISSN: 1462-0324